Login / Signup
Letter: PCSK9 inhibitor for liver transplant patients during the post-statin era? Authors' reply.
Chiara Becchetti
Melisa Dirchwolf
Annalisa Berzigotti
Jaime Bosch
Published in:
Alimentary pharmacology & therapeutics (2022)
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
cardiovascular disease
coronary artery disease
peritoneal dialysis
patient reported outcomes
low density lipoprotein
patient reported